Substituted E-3-(2-chloro-3-indolylmethylene)1,3-dihydroindol-2-ones with antitumor activity.: Effect on the cell cycle and apoptosis

被引:26
作者
Andreani, Aldo
Burnelli, Silvia
Granaiola, Massimiliano
Leoni, Alberto
Locatelli, Alessandra
Morigi, Rita
Rambaldi, Mirella
Varoli, Lucilla
Calonghi, Natalia
Cappadone, Concettina
Farruggia, Giovanna
Zini, Maddalena
Stefanelli, Claudio
Masotti, Lanfranco
机构
[1] Univ Bologna, Dipartimento Sci Farmceut, I-40126 Bologna, Italy
[2] Univ Bologna, Dipartimento Biochim G Moruzzi, I-40126 Bologna, Italy
关键词
D O I
10.1021/jm070235m
中图分类号
R914 [药物化学];
学科分类号
100701 [药物化学];
摘要
The synthesis and antitumor activity of new E-3-(2-chloro-3-indolylmethylene)1,3-dihydroindol-2-ones is described. They were studied at the National Cancer Institute, taking into consideration the 50% growth inhibitory power (pGI(50)), the cytostatic effect (pTGI = total growth inhibition), and the cytotoxic effect (pLC(50)). All the compounds were potent growth inhibitors, with mean pGI(50) ranging from 5.26 to 7.72. They were also analyzed with NCI COMPARE algorithm. Further studies were dedicated to the effects on the cell cycle and apoptosis.
引用
收藏
页码:3167 / 3172
页数:6
相关论文
共 25 条
[1]
Synthesis and potential coanthracyclinic activity of pyridylmethylene and indolylmethylene lactams [J].
Andreani, A ;
Locatelli, A ;
Leoni, A ;
Morigi, R ;
Chiericozzi, M ;
Fraccari, A ;
Galatulas, I ;
Salvatore, G .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1998, 33 (11) :905-909
[2]
Andreani A, 1996, ANTICANCER RES, V16, P3585
[3]
Substituted E-3-(2-chloro-3-indolylmethylene)1, 3-dihydroindol-2-ones with antitumor activity [J].
Andreani, A ;
Granaiola, M ;
Leoni, A ;
Locatelli, A ;
Morigi, R ;
Rambaldi, M ;
Garaliene, V ;
Farruggia, G ;
Masotti, L .
BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (05) :1121-1128
[4]
ANDREANI A, 1979, FARMACO-ED SCI, V34, P132
[5]
Synthesis and antitumor activity of 1,5,6-substituted E-3-(2-chloro-3-indolylmethylene)-1,3-dihydroindol-2-ones [J].
Andreani, A ;
Granaiola, M ;
Leoni, A ;
Locatelli, A ;
Morigi, R ;
Rambaldi, M ;
Garaliene, V .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (12) :2666-2669
[6]
Synthesis and antitumor activity of guanylhydrazones from 6-(2,4-dichloro-5-nitrophenyl)imidazo[2,1-b]thiazoles and 6-pyridylimidazo[2,1-b]thiazoles [J].
Andreani, Aldo ;
Burnelli, Silvia ;
Granaiola, Massimiliano ;
Leoni, Alberto ;
Locatelli, Alessandra ;
Morigi, Rita ;
Rambaldi, Mirella ;
Varoli, Lucilla ;
Farruggia, Giovanna ;
Stefanelli, Claudio ;
Masotti, Lanfranco ;
Kunkel, Mark W. .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (26) :7897-7901
[7]
SOME EXTENSIONS OF THE SYNTHESIS OF HYDROXYINDOLES FROM PARA-BENZOQUINONES [J].
BEER, RJS ;
DAVENPORT, HF ;
ROBERTSON, A .
JOURNAL OF THE CHEMICAL SOCIETY, 1953, (APR) :1262-1264
[8]
Multiple mechanisms of action of ZR2002 in human breast cancer cells: A novel combi-molecule designed to block signaling mediated by the ERB family of oncogenes and to damage genomic DNA [J].
Brahimi, F ;
Rachid, Z ;
Qiu, QY ;
McNamee, JP ;
Li, YJ ;
Tari, AM ;
Jean-Claude, BJ .
INTERNATIONAL JOURNAL OF CANCER, 2004, 112 (03) :484-491
[9]
Comparison of the activities of the truncated halichondrin B analog NSC 707389 (E7389) with those of the parent compound and a proposed binding site on tubulin [J].
Dabydeen, Donnette A. ;
Burnett, James C. ;
Bai, Ruoli ;
Verdier-Pinard, Pascal ;
Hickford, Sarah J. H. ;
Pettit, George R. ;
Blunt, John W. ;
Munro, Murray H. G. ;
Gussio, Rick ;
Hamel, Ernest .
MOLECULAR PHARMACOLOGY, 2006, 70 (06) :1866-1875
[10]
Fodstad O, 1996, J Exp Ther Oncol, V1, P119